181
Views
52
CrossRef citations to date
0
Altmetric
Original Research

Retinal reperfusion in diabetic retinopathy following treatment with anti-VEGF intravitreal injections

, , , , , & show all
Pages 193-200 | Published online: 21 Jan 2017

References

  • Early Treatment Diabetic Retinopathy Study Research GroupETDRS Report No. 12: Fundus photographic risk factors for progression of diabetic retinopathyOphthalmology1991985 Suppl8238332062515
  • LiewGSimDAKeanePADiabetic macular ischaemia is associated with narrower retinal arterioles in patients with type 2 diabetesActa Ophthalmol2015931e45e5125613127
  • RoySMaielloMLorenziMIncreased expression of basement membrane collagen in human diabetic retinopathyJ Clin Invest19949314384428282817
  • YamagishiSAmanoSInagakiYAdvanced glycosylation end products-induced apoptosis and overexpression of vascular endothelial growth factor in bovine retinal pericytesBiochem Biophys Res Commun2002290397397811798169
  • OzakiHYuAYDellaNHypoxia inducible factor-1-alpha is increased in ischemic retina: temporal and spatial correlation with VEGF expressionInvest Ophthalmol Vis Sci19994011821899888442
  • KellyBDHackettSFHirotaKCell type-specific regulation of angiogenic growth factor gene expression and induction of angiogenesis in nonischemic tissue by a constitutively active form of hypoxia-inducible factor 1Circ Res200393111074108114576200
  • AielloLPAveryRLArriggPGVascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disordersN Engl J Med199433122148014877526212
  • AdamisAPMillerJWBernalMTIncreased endothelial growth factor levels in the vitreous of eyes with proliferative diabetic retinopathyAm J Ophthalmol199411844454507943121
  • TolentinoMJMillerJWGragoudasESIntravitreous injections of vascular endothelial growth factor produce retinal ischemia and microangiopathy in an adult primateOphthalmology199610311182018288942877
  • QaumTXuQJoussanAMVEGF-initiated blood-retinal barrier break-down in early diabetesInvest Ophthalmol Vis Sci200142102408241311527957
  • NguyenQDBrownDMMarcusDMRanibizumab for diabetic macular edema: results from 2 phase III randomized trials: RISE and RIDEOphthalmology2012119478980122330964
  • KorobelnikJFDoDVSchmidt-ErfurthUIntravitreal aflibercept for diabetic macular edemaOphthalmology2014121112247225425012934
  • ElmanMJBresslerNMQinHThe Diabetic Retinopathy Clinical Research NetworkExpanded 2-year follow-up of ranibizumab plus prompt or deferred laser or triamcinolone plus prompt laser for diabetic macular edemaOphthalmology2011118460961421459214
  • IpMSDomalpallyASunJKEhrlichJSLong-term effects of therapy with ranibizumab on diabetic retinopathy severity and baseline risk factors for worsening retinopathyOphthalmology2015122236737425439595
  • CampochiaroPAWykoffCCShapiroHRubioRGEhrlichJSNeutralization of vascular endothelial growth factor slows progression of retinal nonperfusion in patients with diabetic macular edemaOphthalmology201412191783178924768239
  • WesselMMAakerGDParlitsisGChoMD’AmicoDJKissSUltra-widefield angiography improves the detection and classification of diabetic retinopathyRetina201232478579122080911
  • SilvaPSCavalleranoJDSunJKSolimanAZAielloLMAielloLPPeripheral lesions identified by mydriatic ultra-wide field imaging: distribution and potential impact on diabetic retinopathy severityOphthalmology20131202587259523778092
  • SilvaPSCavalleranoJDHaddadNMNPeripheral lesions identified on ultrawide field imaging predict increased risk of diabetic retinopathy progression over 4 yearsOphthalmology2015122594995625704318
  • CampochiaroPABhisitkulRBShapiroHRubioRGVascular endothelial growth factor promotes progressive retinal nonperfusion in patients with retinal vein occlusionOphthalmology2013120479580223260261
  • HurwitzHFehrenbacherLNovotnyNBevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancerN Engl J Med2004350232335234215175435
  • SaltzLBClarkeSDiaz-RubioEBevacizumab in combination with oxaliplatin-based chemotherapy as first-line therapy in metastatic colorectal cancer: a randomized phase III studyJ Clin Oncol200826122013201918421054
  • TebbuttNCWilsonKGebskiVJCapecitabine, bevacizumab, and mitomycin in first-line treatment of metastatic colorectal cancer: results of the Australasian Gastrointestinal Trials Group Randomized Phase III MAX StudyJ Clin Oncol201028193191319820516443
  • GiantonioBJCatalanoPJMeropolNJBevacizumab in combination with oxaliplatin, fluorouracil, and leucovorin (FOLFOX4) for previously treated metastatic colorectal cancer: results from the Eastern Cooperative Oncology Group Study E3200J Clin Oncol200725121539154417442997
  • DicksonPVHamnerJBSimsTLBevacizumab-induced transient remodeling of the vasculature in neuroblastoma xenografts results in improved delivery and efficacy of systemically administered chemotherapyClin Cancer Res200713133942395017606728
  • TetsuichiroIMancusoMHashizumeHInhibition of vascular endothelial growth factor (VEGF) signaling in cancer causes loss of endothelial fenestrations, regression of tumor vessels, and appearance of basement membrane ghostsAm J Pathol2004165135395215215160
  • TakahashiKKishiSMuraokaKShimizuKReperfusion of occluded capillary beds in diabetic retinopathyAm J Ophthalmol199812667917979860002
  • The Diabetic Retinopathy Clinical Research NetworkAflibercept, bevacizumab, or ranibizumab for diabetic macular edemaN Engl J Med2015372131193120325692915